Page last updated: 2024-09-05

varenicline and ADDH

varenicline has been researched along with ADDH in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's3 (42.86)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Kalin, NH1
Baker, NL; Ferguson, PL; Gray, KM; Green, R; Hashemi, D1
Bidwell, LC; Bryan, AD; Hutchison, KE; Karoly, HC1
Geyer, MA; Phillips, AG; Robbins, TW1
Cocores, JA; Gold, MS1
Furberg, CD; Glenmullen, J; Moore, TJ1
Moorman, KL; Whitley, HP1

Reviews

1 review(s) available for varenicline and ADDH

ArticleYear
Effective Use of Animal Models for Therapeutic Development in Psychiatric and Substance Use Disorders.
    Biological psychiatry, 2018, 06-01, Volume: 83, Issue:11

    Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Depressive Disorder; Drug Discovery; Humans; Ketamine; Mental Disorders; Models, Animal; Nicotinic Agonists; Tobacco Use Disorder; Varenicline

2018

Trials

1 trial(s) available for varenicline and ADDH

ArticleYear
ADHD symptoms and smoking outcomes in a randomized controlled trial of varenicline for adolescent and young adult tobacco cessation.
    Drug and alcohol dependence, 2023, 03-01, Volume: 244

    Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Cigarette Smoking; Double-Blind Method; Humans; Tobacco Use Cessation; Treatment Outcome; Varenicline; Young Adult

2023

Other Studies

5 other study(ies) available for varenicline and ADDH

ArticleYear
Insights Into Improving Clinical Outcomes Across Psychiatric Disorders and Medical Comorbidities.
    The American journal of psychiatry, 2021, 09-01, Volume: 178, Issue:9

    Topics: Alcoholism; Anorexia Nervosa; Attention Deficit Disorder with Hyperactivity; Comorbidity; Humans; Mental Disorders; Methadone; Naltrexone; Narcotics; Patient Outcome Assessment; Schizophrenia; Smoking; Varenicline

2021
ADHD symptoms impact smoking outcomes and withdrawal in response to Varenicline treatment for smoking cessation.
    Drug and alcohol dependence, 2017, 10-01, Volume: 179

    Topics: Attention Deficit Disorder with Hyperactivity; Conduct Disorder; Humans; Hyperkinesis; Impulsive Behavior; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline

2017
Varenicline and adult ADHD.
    The Journal of neuropsychiatry and clinical neurosciences, 2008,Fall, Volume: 20, Issue:4

    Topics: Adult; Attention Deficit Disorder with Hyperactivity; Benzazepines; Female; Humans; Nicotinic Antagonists; Psychiatric Status Rating Scales; Quinoxalines; Varenicline

2008
Prescription drugs associated with reports of violence towards others.
    PloS one, 2010, Dec-15, Volume: 5, Issue:12

    Topics: Adverse Drug Reaction Reporting Systems; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Benzazepines; Humans; Hypnotics and Sedatives; Outcome Assessment, Health Care; Pharmaceutical Preparations; Prescription Drugs; Prospective Studies; Quinoxalines; United States; United States Food and Drug Administration; Varenicline; Violence

2010
Interference with smoking-cessation effects of varenicline after administration of immediate-release amphetamine-dextroamphetamine.
    Pharmacotherapy, 2007, Volume: 27, Issue:10

    Topics: Adolescent; Amphetamines; Attention Deficit Disorder with Hyperactivity; Benzazepines; Central Nervous System Stimulants; Dextroamphetamine; Drug Combinations; Drug Interactions; Humans; Male; Quinoxalines; Recurrence; Smoking; Smoking Cessation; Time Factors; Treatment Outcome; Varenicline

2007